None listed
Conditions
Brief summary
There has been limited uptake of population screening for colorectal cancer in Australia and other western countries, using faecal occult blood testing. We have previously determined that the InSure faecal immunochemical test (FIT) used in single sample format has similar sensitivity for significant colorectal neoplasia (cancer and significant adenomas) relative to the standard two stool sample test. Our hypothesis is that single stool sampling will result in improved population participation in screening compared to the standard InSure test. This study will compare population participation in screening in two groups, one offered the screening test in single stool sample format, compared to the control (standard InSure test, 2 stool sample format).
Interventions
Participation at 12 weeks from offer of screening for colorectal cancer in the intervention group using a screening test requiring only a single stool sample to be collected for testing for occult blood.
Sponsors
Prof Graeme Young, Dept of Medicine, Flinders University of South Australia
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
50 Years to 74 Years
Healthy volunteers
No
Inclusion criteria
Residing in specific postcodes in southern Adelaide.
Exclusion criteria
Specified pre-existing clinical conditions that makes FOBT-screening uninformative or that preclude follow-up colonoscopy, people already participating in other Bowel Health Service research studies.
Outcome results
None listed